BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15023390)

  • 1. Escalated median dose for pituitary macroadenomas using intensity-modulated radiation therapy.
    Robinson D; Murray B; Underwood L; Halls S; Roa W
    Med Dosim; 2004; 29(1):26-30. PubMed ID: 15023390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.
    Parhar PK; Duckworth T; Shah P; DeWyngaert JK; Narayana A; Formenti SC; Shah JN
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):379-84. PubMed ID: 20015598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with RTOG 93-11 dose-escalation protocol.
    Underwood LJ; Murray BR; Robinson DM; Field GC; Roa WH
    Med Dosim; 2003; 28(3):167-70. PubMed ID: 14563435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
    Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
    van der Geld YG; van Triest B; Verbakel WF; van Sörnsen de Koste JR; Senan S; Slotman BJ; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1215-20. PubMed ID: 18954715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
    Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisegmented tangential breast fields: a rational way to treat breast cancer.
    Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
    Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
    Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
    Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
    Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.